Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STUNNIN: SBRT +/- STAD in Prostate Cancer
NCT05557604Phase 2Recruiting
- Sponsor
- IRCCS Regina Elena National Cancer Institute
- Start
- Feb 2021
- Primary completion
- Feb 2024
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of triptorelin in prostate cancer (PCa), sponsored by IRCCS Regina Elena National Cancer Institute. Started Feb 2021; status: recruiting.
02
Drugs
triptorelin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT05557604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05557604.